An Iterative Design Approach to Development of an Ex Situ Normothermic Multivisceral Perfusion Platform
Journal of Clinical Medicine · 30.06.2025 · 14 (13) · 4620
DOI: 10.3390/jcm14134620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.06.2025. Verfasst von L Leonie van Leeuwen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Organ Perfusion Unit, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, 1468 Madison Ave, New York City, NY 10029, …. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Blavatnik Family Foundation.
Abstract (Originalsprache)
Background/Objectives: Challenges in normothermic machine perfusion (NMP) remain, particularly concerning the duration for which individual organs can be safely preserved. We hypothesize that optimal preservation can be achieved by perfusing organs together in a multivisceral block. Therefore, our aim was to establish a platform for ex situ multivisceral organ perfusion.
Methods
Multivisceral grafts containing the liver, kidneys, pancreas, spleen, and intestine were obtained from Yorkshire pigs. Three generation (gen) set-ups were tested during the iterative design process, and minor changes were made throughout. Gen 1 (n = 4) used a custom-designed single perfusion circuit. Gen 2 (n = 3) employed a dual perfusion circuit. Gen 3 (n = 4) featured a single perfusion circuit with an optimized basin and reservoir. Grafts underwent NMP using an autologous blood-based perfusate, while hemostatic parameters and function were assessed.
Results
Comparing Gen 1 versus Gen 3, the mean aortic flow improved (1.018 vs. 2.089 L), resistance decreased (0.224 vs. 0.038), urine output increased (51.90 vs. 271.3 mL), oxygen consumption rose (43.56 vs. 49.52 mL O2/min), perfusate lactate levels dropped (10.44 vs. 3.10 mmol/L), and the pH became more physiological (7.27 vs. 7.30). Cellular injury trended lower in Gen 3. Histological evaluation demonstrated minimal differences in Gens 2 and 3.
Conclusions
We demonstrate the feasibility of abdominal multivisceral NMP for up to 8 h. Adequate arterial flow, stable perfusate pH, and high oxygen consumption in setup 3 indicated organ viability. Multivisceral perfusion may serve as a plat-form for long-term NMP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Organ Perfusion Unit, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, 1468 Madison Ave, New York City, NY 10029, USA.
ORCID-Profile: Matthew L Holzner, Ceilidh McKenney, Rachel Todd, Jamie K Frost, Leona Kim-Schluger, Sander Florman
Förderung
- Blavatnik Family Foundation
Zitieren
APA
van Leeuwen, L. L., Holzner, M. L., McKenney, C., Todd, R., Frost, J. K., Gudibendi, S., Kim-Schluger, L., Schiano, T., Florman, S., & Akhtar, M. Z. (2025). An Iterative Design Approach to Development of an Ex Situ Normothermic Multivisceral Perfusion Platform. Journal of Clinical Medicine, 14(13), 4620. https://doi.org/10.3390/jcm14134620
Vancouver
van Leeuwen LL, Holzner ML, McKenney C, Todd R, Frost JK, Gudibendi S, et al. An Iterative Design Approach to Development of an Ex Situ Normothermic Multivisceral Perfusion Platform. Journal of Clinical Medicine. 2025;14(13):4620. doi:10.3390/jcm14134620
BibTeX
@article{vanLeeuwen2025,
author = {van Leeuwen, L Leonie and Holzner, Matthew L and McKenney, Ceilidh and Todd, Rachel and Frost, Jamie K and Gudibendi, Sneha and Kim-Schluger, Leona and Schiano, Thomas and Florman, Sander and Akhtar, M Zeeshan},
title = {An Iterative Design Approach to Development of an Ex Situ Normothermic Multivisceral Perfusion Platform},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {13},
pages = {4620},
doi = {10.3390/jcm14134620}
}
EUVIMED